Published in Glimpse on October 01, 1996
Test for enterotoxigenic Escherichia coli using Y-1 adrenal cells in miniculture. Infect Immun (1975) 13.58
Human diarrheal disease caused by enterotoxigenic Escherichia coli. Annu Rev Microbiol (1975) 9.01
Enterotoxigenic Escherichia coli isolated from patients with severe cholera-like disease. J Infect Dis (1971) 7.10
Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress. N Engl J Med (1976) 6.52
Acute undifferentiated human diarrhea in the tropics. I. Alterations in intestinal micrflora. J Clin Invest (1971) 6.23
Large outbreak of clinical cholera due to Vibrio cholerae non-O1 in Bangladesh. Lancet (1993) 5.48
Immunologic cross-reactions of enterotoxins from Escherichia coli and Vibrio cholerae. J Infect Dis (1973) 5.46
Enzyme-linked immunosorbent assay for detection of Escherichia coli heat-labile enterotoxin. J Clin Microbiol (1977) 5.17
Special Escherichia coli serotypes among enterotoxigenic strains from diarrhoea in adults and children. Med Microbiol Immunol (1976) 4.95
Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet (1990) 4.62
Practice guidelines for the management of infectious diarrhea. Clin Infect Dis (2001) 4.49
Experimental canine cholera. I. Development of the model. J Infect Dis (1969) 4.02
A two-year study of bacterial, viral, and parasitic agents associated with diarrhea in rural Bangladesh. J Infect Dis (1980) 3.96
Site and characteristics of electrolyte loss and effect of intraluminal glucose in experimental canine cholera. J Clin Invest (1968) 3.72
Simple adult rabbit model for Vibrio cholerae and enterotoxigenic Escherichia coli diarrhea. Infect Immun (1981) 3.69
Cytotoxic enterotoxin produced by Aeromonas hydrophila: relationship of toxigenic isolates to diarrheal disease. Infect Immun (1979) 3.65
Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum (1981) 3.55
Enterotoxigenic Escherichia coli isolated from food. J Infect Dis (1977) 3.52
Laboratory investigation of diarrhea in travelers to Mexico: evaluation of methods for detecting enterotoxigenic Echerichia coli. J Clin Microbiol (1976) 3.34
Diarrhoea associated with heat-stable enterotoxin-producing strains of Escherichia coli. Lancet (1975) 3.27
Oral rehydration therapy of infantile diarrhea: a controlled study of well-nourished children hospitalized in the United States and Panama. N Engl J Med (1982) 3.24
Case-control study of enteropathogens associated with childhood diarrhea in Dhaka, Bangladesh. J Clin Microbiol (1999) 3.11
Intestinal fluid and electrolyte transport in human cholera. J Clin Invest (1970) 3.09
A controlled trial of bismuth subsalicylate in infants with acute watery diarrheal disease. N Engl J Med (1993) 3.07
Progressive changes of Vibrio serotypes in germ-free mice infected with Vibrio cholerae. J Bacteriol (1969) 3.01
Are diarrhoea control programmes likely to reduce childhood malnutrition? Observations from rural Bangladesh. Lancet (1989) 2.90
Antitoxin responses to infections with enterotoxigenic Escherichia coli. J Infect Dis (1974) 2.88
Prophylactic doxycycline for travelers' diarrhea. Results of a prospective double-blind study of Peace Corps volunteers in Kenya. N Engl J Med (1978) 2.86
Field trial of oral cholera vaccines in Bangladesh. Lancet (1986) 2.85
Enterotoxigenic Escherichia-coli-associated diarrheal disease in Apache children. N Engl J Med (1975) 2.74
Microtiter solid-phase radioimmunoassay for detection of Escherichia coli heat-labile enterotoxin. Infect Immun (1977) 2.72
Prevalence of toxin types and colonization factors in enterotoxigenic Escherichia coli isolated during a 2-year period from diarrheal patients in Bangladesh. J Clin Microbiol (2000) 2.69
Reduction of cholera in Bangladeshi villages by simple filtration. Proc Natl Acad Sci U S A (2003) 2.68
Vibriocidal and agglutinating antibody patterns in cholera patients. J Infect Dis (1966) 2.67
Diarrhoeal mortality in two Bangladeshi villages with and without community-based oral rehydration therapy. Lancet (1979) 2.66
Incidence and severity of rotavirus and Escherichia coli diarrhoea in rural Bangladesh. Implications for vaccine development. Lancet (1981) 2.65
El Tor cholera with severe disease: a new threat to Asia and beyond. Epidemiol Infect (2009) 2.60
Isolation of enterotoxigenic Bacteroides fragilis from humans with diarrhea. J Clin Microbiol (1987) 2.58
Methodological issues in diarrhoeal diseases epidemiology: definition of diarrhoeal episodes. Int J Epidemiol (1991) 2.56
Predisposition for cholera of individuals with O blood group. Possible evolutionary significance. Am J Epidemiol (1985) 2.49
Human colonic epithelial cells, HT29/C1, treated with crude Bacteroides fragilis enterotoxin dramatically alter their morphology. Infect Immun (1992) 2.41
Genotypes associated with virulence in environmental isolates of Vibrio cholerae. Appl Environ Microbiol (2001) 2.41
Serological evidence for the identity of the vascular permeability factor and ileal loop toxin of Vibrio cholerae. J Infect Dis (1970) 2.29
Replacement of water and electrolyte losses in cholera by an oral glucose-electrolyte solution. Ann Intern Med (1969) 2.28
Twenty-four-hour recall, knowledge-attitude-practice questionnaires, and direct observations of sanitary practices: a comparative study. Bull World Health Organ (1987) 2.24
Tissue-culture assay of antibodies to heat-liable Escherichia coli enterotoxins. N Engl J Med (1974) 2.20
Amebiasis and mucosal IgA antibody against the Entamoeba histolytica adherence lectin in Bangladeshi children. J Infect Dis (2001) 2.20
Enterotoxigenic Escherichia coli: identification and characterization. J Infect Dis (1980) 2.16
An outbreak of dysentery caused by Shigella dysenteriae type 1 on a coral island in the Bay of Bengal. J Infect Dis (1975) 2.15
Immunity to experimental cholera. III. Enhanced duration of protection after sequential parenteral-oral administration of toxoid to dogs. J Infect Dis (1977) 2.13
Classical Vibrio cholerae biotype displaces EL tor in Bangladesh. Lancet (1983) 2.12
Small bowel morphology in experimental canine cholera. A light and electron microscopic study. Lab Invest (1970) 2.12
Production, characterization, and application of monoclonal antibodies to Vibrio cholerae O139 synonym Bengal. Clin Diagn Lab Immunol (1994) 2.07
Synergistic impact of measles and diarrhoea on nutrition and mortality in Bangladesh. Bull World Health Organ (1981) 2.06
The aquatic flora and fauna as reservoirs of Vibrio cholerae: a review. J Diarrhoeal Dis Res (1994) 2.04
Enterotoxigenic Escherichia coli isolated from patients at a hospital in Dacca. J Infect Dis (1977) 2.03
Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1. Infect Immun (1997) 2.01
Relationship between enterotoxin production and serotype in enterotoxigenic Escherichia coli. Infect Immun (1979) 2.01
Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. I. Study design and results of the first year of observation. Bull World Health Organ (1969) 2.00
Emergence of multiply antibiotic-resistant Vibrio cholerae in Bangladesh. J Infect Dis (1980) 1.97
Maternal mortality in rural Bangladesh. Stud Fam Plann (1974) 1.97
Antimicrobial resistance in organisms causing diarrheal disease. Clin Infect Dis (1997) 1.95
Cholera epidemics in Bangladesh: 1985-1991. J Diarrhoeal Dis Res (1992) 1.92
Enteropathogens associated with acute and persistent diarrhea in Bangladeshi children less than 5 years of age. J Infect Dis (1992) 1.91
Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1. Clin Diagn Lab Immunol (1995) 1.89
Use of colony pools for diagnosis of enterotoxigenic Escherichia coli diarrhea. J Clin Microbiol (1979) 1.88
Enterotoxigenic Escherichia coli diarrhea of travelers: a prospective study of American Peace Corps volunteers. Johns Hopkins Med J (1977) 1.88
Experimental cholera. A canine model. Lancet (1966) 1.88
Acute toxicity of vitamin A given with vaccines in infancy. Lancet (1993) 1.87
Immunization with Escherichia coli enterotoxin protects against homologous enterotoxin challenge. Infect Immun (1973) 1.86
Prevalence of enterotoxin genes in Aeromonas spp. isolated from children with diarrhea, healthy controls, and the environment. J Clin Microbiol (2000) 1.85
Prophylactic doxycycline for travelers' diarrhea: results of a prospective double-blind study of Peace Corps volunteers in Morocco. Gastroenterology (1979) 1.84
Molecular analysis of rRNA and cholera toxin genes carried by the new epidemic strain of toxigenic Vibrio cholerae O139 synonym Bengal. J Clin Microbiol (1994) 1.79
The O139 serogroup of Vibrio cholerae comprises diverse clones of epidemic and nonepidemic strains derived from multiple V. cholerae O1 or non-O1 progenitors. J Infect Dis (2000) 1.76
Quality of care for under-fives in first-level health facilities in one district of Bangladesh. Bull World Health Organ (2005) 1.76
Epidemiology of eltor cholera in rural Bangladesh: importance of surface water in transmission. Bull World Health Organ (1982) 1.75
Antibodies to heat-labile Escherichia coli enterotoxin in Apaches in Whiteriver, Arizona. Infect Immun (1975) 1.75
Zinc for severe pneumonia in very young children: double-blind placebo-controlled trial. Lancet (2004) 1.74
Integrating health services into an MCH-FP program: lessons from Matlab, Bangladesh. Stud Fam Plann (1984) 1.74
Maternal mortality in Matlab, Bangladesh: 1976-85. Stud Fam Plann (1988) 1.73
Experimental canine cholera. II. Production by cell-free culture filtrates of Vibrio cholerae. J Infect Dis (1969) 1.69
Enterotoxigenic Escherichia coli and idiopathic diarrhoea in Bangladesh. Lancet (1975) 1.67
New insights on the emergence of cholera in Latin America during 1991: the Peruvian experience. Am J Trop Med Hyg (2000) 1.66
The spatial epidemiology of cholera in an endemic area of Bangladesh. Soc Sci Med (2002) 1.65
Acute respiratory infections in children: a community-based longitudinal study in rural Bangladesh. J Trop Pediatr (1997) 1.64
Ecology of Vibrio mimicus in aquatic environments. Appl Environ Microbiol (1989) 1.62
Coexistence of Vibrio cholerae O1 and O139 Bengal in plankton in Bangladesh. Lancet (1995) 1.59
Effect of glycine and glucose on sodium and water adsorption in patients with cholera. Gut (1970) 1.59
Genomic profiles of clinical and environmental isolates of Vibrio cholerae O1 in cholera-endemic areas of Bangladesh. Proc Natl Acad Sci U S A (2002) 1.59
Antigenic similarity of heat-labile enterotoxins from diverse strains of Escherichia coli. J Clin Microbiol (1977) 1.55
Identifying environmental risk factors for endemic cholera: a raster GIS approach. Health Place (2002) 1.49
Longitudinal studies of infectious diseases and physical growth of children in rural Bangladesh. I. Patterns of morbidity. Am J Epidemiol (1982) 1.49
B subunit-whole cell and whole cell-only oral vaccines against cholera: studies on reactogenicity and immunogenicity. J Infect Dis (1987) 1.47
Development and evaluation of rapid monoclonal antibody-based coagglutination test for direct detection of Vibrio cholerae O139 synonym Bengal in stool samples. J Clin Microbiol (1994) 1.47
The efficacy of bismuth subsalicylate in the treatment of acute diarrhoea and the prevention of persistent diarrhoea. Acta Paediatr (2001) 1.47